|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
ETRANACOGENE DEZAPARVOVEC |
B06XX00 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/004827 |
20-02-2023 |
VALID
|
|
GALLIUM (68GA) GOZETOTIDE |
V09IX14 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005488 |
09-12-2022 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN |
V10XX05 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005483 |
09-12-2022 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
MARIBAVIR |
J05AX10 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
MITAPIVAT |
B06AX04 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
TREMELIMUMAB |
L01FX20 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/004650 |
20-02-2023 |
VALID
|
|
IRINOTECAN |
L01CE02 |
IT
|
I
|
06-09-2023 |
|
|
VALID
|
|
ATOGEPANT |
N02CD07 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005871 |
11-08-2023 |
VALID
|
|
FUTIBATINIB |
L01EN04 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005627 |
04-07-2023 |
VALID
|
|
GANAXOLONE |
N03AX27 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005825 |
26-07-2023 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005618 |
04-05-2023 |
VALID
|
|
PIFLUFOLASTAT (18F) |
V09IX16 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005520 |
24-07-2023 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
RITLECITINIB |
L04AF08 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005919 |
15-09-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
|
DESOGESTREL |
G03AC09 |
IT
|
II
|
07-02-2024 |
|
|
VALID
|
|
ESTRADIOL |
G03CA03 |
IT
|
I
|
07-02-2024 |
|
|
VALID
|
|
ETHINYLESTRADIOL |
G03CA01 |
IT
|
Not authorised
|
07-02-2024 |
|
|
VALID
|
|
MACROGOL |
A06AD15 |
IT
|
II + Exemption
|
07-02-2024 |
|
|
VALID
|
|
OLMESARTAN MEDOXOMIL AND DIURETICS |
C09DA08 |
IT
|
II
|
07-02-2024 |
|
|
VALID
|
|
SIMVASTATIN AND FENOFIBRATE |
C10BA04 |
IT
|
II
|
07-02-2024 |
|
|
VALID
|
|
CONJUGATED ESTROGENS |
G03CA57 |
IT
|
Not authorised
|
08-02-2024 |
|
|
VALID
|
|
CONJUGATED ESTROGENS AND BAZEDOXIFENE |
G03CC07 |
IT
|
II
|
08-02-2024 |
|
|
VALID
|
|
CYPROTERONE |
G03HA01 |
IT
|
I
|
08-02-2024 |
|
|
VALID
|
|
NORETHISTERONE AND ESTROGEN |
G03FB05 |
IT
|
I
|
08-02-2024 |
|
|
VALID
|
|
PREDNISOLONE |
H02AB06 |
IT
|
I
|
08-02-2024 |
|
11-02-2002 |
VALID
|
|
PROMESTRIENE |
G03CA09 |
IT
|
II
|
08-02-2024 |
|
|
VALID
|
|
TERLIPRESSIN |
H01BA04 |
IT
|
I
|
08-02-2024 |
|
11-02-2002 |
VALID
|
|
TIBOLONE |
G03CX01 |
IT
|
I
|
22-02-2024 |
|
|
VALID
|
|
ADAGRASIB |
L01XX77 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/006013 |
05-01-2024 |
VALID
|
|
CEFEPIME AND BETA-LACTAMASE INHIBITOR |
J01DE51 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005431 |
21-03-2024 |
VALID
|
|
ELRANATAMAB |
L01FX32 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005908 |
07-12-2023 |
VALID
|
|
ETRASIMOD |
L04AE05 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
EXAGAMGLOGENE AUTOTEMCEL |
B06AX05 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005763 |
09-02-2024 |
VALID
|
|
FEZOLINETANT |
G02CX06 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
